Balasa Dinverno & Foltz’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $7.83M | Buy |
15,494
+508
| +3% | +$267K | 0.49% | 26 |
|
|
2022
Q2 | $7.7M | Buy |
14,986
+1,283
| +9% | +$644K | 0.48% | 25 |
|
|
2022
Q1 | $6.99M | Buy |
13,703
+943
| +7% | +$455K | 0.47% | 26 |
|
|
2021
Q4 | $6.41M | Buy |
12,760
+347
| +3% | +$157K | 0.41% | 28 |
|
|
2021
Q3 | $4.85M | Buy |
12,413
+1,374
| +12% | +$569K | 0.34% | 31 |
|
|
2021
Q2 | $4.42M | Buy |
11,039
+675
| +7% | +$269K | 0.32% | 31 |
|
|
2021
Q1 | $3.86M | Buy |
10,364
+888
| +9% | +$308K | 0.31% | 31 |
|
|
2020
Q4 | $3.32M | Buy |
9,476
+481
| +5% | +$161K | 0.28% | 35 |
|
|
2020
Q3 | $2.8M | Buy |
8,995
+427
| +5% | +$131K | 0.27% | 37 |
|
|
2020
Q2 | $2.53M | Buy |
8,568
+136
| +2% | +$39K | 0.28% | 33 |
|
|
2020
Q1 | $2.1M | Sell |
8,432
-54
| -0.6% | -$14.9K | 0.26% | 40 |
|
|
2019
Q4 | $2.5M | Sell |
8,486
-77
| -0.9% | -$20.1K | 0.26% | 42 |
|
|
2019
Q3 | $1.86M | Buy |
8,563
+197
| +2% | +$47.5K | 0.22% | 48 |
|
|
2019
Q2 | $2.04M | Sell |
8,366
-39
| -0.5% | -$9.38K | 0.24% | 42 |
|
|
2019
Q1 | $2.08M | Sell |
8,405
-678
| -7% | -$173K | 0.25% | 38 |
|
|
2018
Q4 | $2.26M | Sell |
9,083
-174
| -2% | -$46K | 0.28% | 36 |
|
|
2018
Q3 | $2.46M | Buy |
9,257
+254
| +3% | +$66.1K | 0.28% | 31 |
|
|
2018
Q2 | $2.21M | Buy |
9,003
+313
| +4% | +$75.2K | 0.32% | 31 |
|
|
2018
Q1 | $1.86M | Buy |
8,690
+7
| +0.1% | +$1.6K | 0.28% | 30 |
|
|
2017
Q4 | $1.91M | Sell |
8,683
-641
| -7% | -$136K | 0.28% | 33 |
|
|
2017
Q3 | $1.83M | Buy |
9,324
+531
| +6% | +$103K | 0.29% | 30 |
|
|
2017
Q2 | $1.63M | Buy |
8,793
+225
| +3% | +$39.5K | 0.27% | 33 |
|
|
2017
Q1 | $1.41M | Buy |
8,568
+80
| +0.9% | +$13.1K | 0.24% | 35 |
|
|
2016
Q4 | $1.36M | Sell |
8,488
-600
| -7% | -$89.6K | 0.23% | 38 |
|
|
2016
Q3 | $1.27M | Buy |
9,088
+258
| +3% | +$36.1K | 0.23% | 35 |
|
|
2016
Q2 | $1.25M | Buy |
8,830
+884
| +11% | +$118K | 0.22% | 34 |
|
|
2016
Q1 | $1.02M | Sell |
7,946
-162
| -2% | -$19.2K | 0.18% | 38 |
|
|
2015
Q4 | $954K | Buy |
8,108
+200
| +3% | +$23.4K | 0.16% | 44 |
|
|
2015
Q3 | $917K | Buy |
7,908
+1,069
| +16% | +$128K | 0.16% | 47 |
|
|
2015
Q2 | $834K | Buy |
6,839
+627
| +10% | +$74.2K | 0.14% | 49 |
|
|
2015
Q1 | $735K | Buy |
6,212
+152
| +3% | +$16.9K | 0.11% | 60 |
|
|
2014
Q4 | $613K | Buy |
6,060
+213
| +4% | +$20.2K | 0.09% | 74 |
|
|
2014
Q3 | $504K | Buy |
5,847
+73
| +1% | +$6.17K | 0.08% | 83 |
|
|
2014
Q2 | $472K | Buy |
5,774
+242
| +4% | +$19K | 0.05% | 84 |
|
|
2014
Q1 | $454K | Sell |
5,532
-110
| -2% | -$8.28K | 0.06% | 82 |
|
|
2013
Q4 | $425K | Buy |
5,642
+70
| +1% | +$5.03K | 0.06% | 83 |
|
|
2013
Q3 | $399K | Sell |
5,572
-107
| -2% | -$7.66K | 0.07% | 74 |
|
|
2013
Q2 | $372K | Buy |
+5,679
| New | +$353K | 0.07% | 75 |
|
Other funds holding UNH
Balasa Dinverno & Foltz's UNH Position: Q3 2022 in Review
Balasa Dinverno & Foltz increased its UnitedHealth (UNH) stake by 3.4% in Q3 2022, buying an estimated $267K and bringing the position to 15,494 shares worth $7.83M. The position accounts for 0.49% of the portfolio, ranked #26.
Balasa Dinverno & Foltz first reported a position in UNH in Q2 2013 and has held it in 38 quarters since. 2,993 funds tracked by Wall St. Rank hold UNH as of Q3 2022.
- Balasa Dinverno & Foltz held 15,494 shares of UnitedHealth worth $7.83M as of Q3 2022.
- Balasa Dinverno & Foltz bought 508 UnitedHealth shares in Q3 2022, an estimated $267K.
- UnitedHealth made up 0.49% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #26 holding.
- Balasa Dinverno & Foltz first reported a position in UnitedHealth in Q2 2013 and has held it in 38 quarters since.
- 2,993 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2022.
Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.